nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—CHRM3—ureter—uterine cancer	0.0851	0.44	CbGeAlD
Hyoscyamine—CHRM3—muscle of abdomen—uterine cancer	0.0613	0.317	CbGeAlD
Hyoscyamine—CHRM3—exocrine gland—uterine cancer	0.0168	0.0867	CbGeAlD
Hyoscyamine—CHRM3—smooth muscle tissue—uterine cancer	0.00703	0.0363	CbGeAlD
Hyoscyamine—CHRM3—renal system—uterine cancer	0.00677	0.035	CbGeAlD
Hyoscyamine—CHRM1—female reproductive system—uterine cancer	0.00606	0.0313	CbGeAlD
Hyoscyamine—CHRM3—female reproductive system—uterine cancer	0.00542	0.028	CbGeAlD
Hyoscyamine—CHRM3—female gonad—uterine cancer	0.00493	0.0255	CbGeAlD
Hyoscyamine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00237	CcSEcCtD
Hyoscyamine—Blood disorder—Doxorubicin—uterine cancer	0.00191	0.00236	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Epirubicin—uterine cancer	0.0019	0.00236	CcSEcCtD
Hyoscyamine—Somnolence—Progesterone—uterine cancer	0.0019	0.00236	CcSEcCtD
Hyoscyamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00235	CcSEcCtD
Hyoscyamine—Dyspepsia—Progesterone—uterine cancer	0.00188	0.00234	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00232	CcSEcCtD
Hyoscyamine—Erythema—Dactinomycin—uterine cancer	0.00185	0.0023	CcSEcCtD
Hyoscyamine—Delirium—Doxorubicin—uterine cancer	0.00185	0.00229	CcSEcCtD
Hyoscyamine—Fatigue—Progesterone—uterine cancer	0.00185	0.00229	CcSEcCtD
Hyoscyamine—Constipation—Progesterone—uterine cancer	0.00183	0.00227	CcSEcCtD
Hyoscyamine—Pain—Progesterone—uterine cancer	0.00183	0.00227	CcSEcCtD
Hyoscyamine—Dysarthria—Epirubicin—uterine cancer	0.00182	0.00225	CcSEcCtD
Hyoscyamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00225	CcSEcCtD
Hyoscyamine—Feeling abnormal—Progesterone—uterine cancer	0.00176	0.00219	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00176	0.00218	CcSEcCtD
Hyoscyamine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00217	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Progesterone—uterine cancer	0.00175	0.00217	CcSEcCtD
Hyoscyamine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00214	CcSEcCtD
Hyoscyamine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00214	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Epirubicin—uterine cancer	0.00172	0.00213	CcSEcCtD
Hyoscyamine—Injection site reaction—Epirubicin—uterine cancer	0.00171	0.00212	CcSEcCtD
Hyoscyamine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00212	CcSEcCtD
Hyoscyamine—Urticaria—Progesterone—uterine cancer	0.0017	0.00211	CcSEcCtD
Hyoscyamine—Dermatitis contact—Epirubicin—uterine cancer	0.0017	0.00211	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Etoposide—uterine cancer	0.00169	0.0021	CcSEcCtD
Hyoscyamine—Abdominal pain—Progesterone—uterine cancer	0.00169	0.0021	CcSEcCtD
Hyoscyamine—Body temperature increased—Progesterone—uterine cancer	0.00169	0.0021	CcSEcCtD
Hyoscyamine—Dysarthria—Doxorubicin—uterine cancer	0.00168	0.00209	CcSEcCtD
Hyoscyamine—Myocardial infarction—Etoposide—uterine cancer	0.00168	0.00209	CcSEcCtD
Hyoscyamine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00207	CcSEcCtD
Hyoscyamine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00206	CcSEcCtD
Hyoscyamine—Skin exfoliation—Epirubicin—uterine cancer	0.00164	0.00204	CcSEcCtD
Hyoscyamine—Blood urea increased—Epirubicin—uterine cancer	0.00162	0.00201	CcSEcCtD
Hyoscyamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00198	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00159	0.00197	CcSEcCtD
Hyoscyamine—Dry eye—Epirubicin—uterine cancer	0.00159	0.00197	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00197	CcSEcCtD
Hyoscyamine—Injection site reaction—Doxorubicin—uterine cancer	0.00158	0.00196	CcSEcCtD
Hyoscyamine—Hypersensitivity—Progesterone—uterine cancer	0.00158	0.00196	CcSEcCtD
Hyoscyamine—Dermatitis contact—Doxorubicin—uterine cancer	0.00157	0.00195	CcSEcCtD
Hyoscyamine—Coma—Epirubicin—uterine cancer	0.00157	0.00195	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Epirubicin—uterine cancer	0.00156	0.00194	CcSEcCtD
Hyoscyamine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00191	CcSEcCtD
Hyoscyamine—Asthenia—Progesterone—uterine cancer	0.00154	0.0019	CcSEcCtD
Hyoscyamine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0019	CcSEcCtD
Hyoscyamine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0019	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Epirubicin—uterine cancer	0.00153	0.0019	CcSEcCtD
Hyoscyamine—Skin exfoliation—Doxorubicin—uterine cancer	0.00152	0.00188	CcSEcCtD
Hyoscyamine—Pruritus—Progesterone—uterine cancer	0.00151	0.00188	CcSEcCtD
Hyoscyamine—Oedema—Dactinomycin—uterine cancer	0.00151	0.00188	CcSEcCtD
Hyoscyamine—Hypertonia—Epirubicin—uterine cancer	0.00151	0.00187	CcSEcCtD
Hyoscyamine—Blood urea increased—Doxorubicin—uterine cancer	0.0015	0.00186	CcSEcCtD
Hyoscyamine—Dry eye—Doxorubicin—uterine cancer	0.00147	0.00182	CcSEcCtD
Hyoscyamine—Diarrhoea—Progesterone—uterine cancer	0.00146	0.00182	CcSEcCtD
Hyoscyamine—Coma—Doxorubicin—uterine cancer	0.00145	0.0018	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Doxorubicin—uterine cancer	0.00145	0.00179	CcSEcCtD
Hyoscyamine—Flushing—Etoposide—uterine cancer	0.00143	0.00177	CcSEcCtD
Hyoscyamine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00177	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Doxorubicin—uterine cancer	0.00142	0.00176	CcSEcCtD
Hyoscyamine—Dizziness—Progesterone—uterine cancer	0.00142	0.00175	CcSEcCtD
Hyoscyamine—Hypertonia—Doxorubicin—uterine cancer	0.0014	0.00173	CcSEcCtD
Hyoscyamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00173	CcSEcCtD
Hyoscyamine—Eczema—Epirubicin—uterine cancer	0.00139	0.00172	CcSEcCtD
Hyoscyamine—Eye pain—Epirubicin—uterine cancer	0.00138	0.00171	CcSEcCtD
Hyoscyamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0017	CcSEcCtD
Hyoscyamine—Vomiting—Progesterone—uterine cancer	0.00136	0.00169	CcSEcCtD
Hyoscyamine—Rash—Progesterone—uterine cancer	0.00135	0.00167	CcSEcCtD
Hyoscyamine—Dermatitis—Progesterone—uterine cancer	0.00135	0.00167	CcSEcCtD
Hyoscyamine—Headache—Progesterone—uterine cancer	0.00134	0.00166	CcSEcCtD
Hyoscyamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00165	CcSEcCtD
Hyoscyamine—Dysgeusia—Etoposide—uterine cancer	0.00131	0.00163	CcSEcCtD
Hyoscyamine—Fatigue—Dactinomycin—uterine cancer	0.0013	0.00162	CcSEcCtD
Hyoscyamine—Pain—Dactinomycin—uterine cancer	0.00129	0.0016	CcSEcCtD
Hyoscyamine—Eczema—Doxorubicin—uterine cancer	0.00129	0.00159	CcSEcCtD
Hyoscyamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00159	CcSEcCtD
Hyoscyamine—Eye pain—Doxorubicin—uterine cancer	0.00128	0.00159	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Epirubicin—uterine cancer	0.00128	0.00159	CcSEcCtD
Hyoscyamine—Lethargy—Epirubicin—uterine cancer	0.00127	0.00158	CcSEcCtD
Hyoscyamine—Nausea—Progesterone—uterine cancer	0.00127	0.00158	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—uterine cancer	0.00125	0.00155	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—uterine cancer	0.00125	0.00155	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dactinomycin—uterine cancer	0.00125	0.00155	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00124	0.00153	CcSEcCtD
Hyoscyamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00153	CcSEcCtD
Hyoscyamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00152	CcSEcCtD
Hyoscyamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00151	CcSEcCtD
Hyoscyamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00151	CcSEcCtD
Hyoscyamine—Vertigo—Etoposide—uterine cancer	0.00121	0.00149	CcSEcCtD
Hyoscyamine—Body temperature increased—Dactinomycin—uterine cancer	0.0012	0.00148	CcSEcCtD
Hyoscyamine—Abdominal pain—Dactinomycin—uterine cancer	0.0012	0.00148	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—uterine cancer	0.00119	0.00147	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—uterine cancer	0.00118	0.00147	CcSEcCtD
Hyoscyamine—Loss of consciousness—Etoposide—uterine cancer	0.00118	0.00146	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—uterine cancer	0.00118	0.00146	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—uterine cancer	0.00117	0.00146	CcSEcCtD
Hyoscyamine—Convulsion—Etoposide—uterine cancer	0.00116	0.00144	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—uterine cancer	0.00116	0.00144	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—uterine cancer	0.00116	0.00144	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—uterine cancer	0.00116	0.00143	CcSEcCtD
Hyoscyamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00143	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—uterine cancer	0.00114	0.00142	CcSEcCtD
Hyoscyamine—Chest pain—Etoposide—uterine cancer	0.00114	0.00142	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—uterine cancer	0.00114	0.00141	CcSEcCtD
Hyoscyamine—Hypersensitivity—Dactinomycin—uterine cancer	0.00111	0.00138	CcSEcCtD
Hyoscyamine—Confusional state—Etoposide—uterine cancer	0.0011	0.00137	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—uterine cancer	0.0011	0.00136	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Etoposide—uterine cancer	0.00109	0.00136	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—uterine cancer	0.00109	0.00135	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—uterine cancer	0.00109	0.00135	CcSEcCtD
Hyoscyamine—Asthenia—Dactinomycin—uterine cancer	0.00109	0.00135	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—uterine cancer	0.00108	0.00134	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—uterine cancer	0.00107	0.00133	CcSEcCtD
Hyoscyamine—Tachycardia—Etoposide—uterine cancer	0.00107	0.00132	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—uterine cancer	0.00106	0.00131	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Etoposide—uterine cancer	0.00106	0.00131	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—uterine cancer	0.00105	0.0013	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—uterine cancer	0.00105	0.0013	CcSEcCtD
Hyoscyamine—Diarrhoea—Dactinomycin—uterine cancer	0.00104	0.00128	CcSEcCtD
Hyoscyamine—Hypotension—Etoposide—uterine cancer	0.00102	0.00127	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—uterine cancer	0.00101	0.00125	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—uterine cancer	0.00101	0.00125	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—uterine cancer	0.000999	0.00124	CcSEcCtD
Hyoscyamine—Dyspnoea—Etoposide—uterine cancer	0.000976	0.00121	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—uterine cancer	0.000974	0.00121	CcSEcCtD
Hyoscyamine—Somnolence—Etoposide—uterine cancer	0.000973	0.00121	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—uterine cancer	0.000973	0.00121	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—uterine cancer	0.000962	0.00119	CcSEcCtD
Hyoscyamine—Vomiting—Dactinomycin—uterine cancer	0.000962	0.00119	CcSEcCtD
Hyoscyamine—Rash—Dactinomycin—uterine cancer	0.000954	0.00118	CcSEcCtD
Hyoscyamine—Fatigue—Etoposide—uterine cancer	0.000944	0.00117	CcSEcCtD
Hyoscyamine—Constipation—Etoposide—uterine cancer	0.000936	0.00116	CcSEcCtD
Hyoscyamine—Pain—Etoposide—uterine cancer	0.000936	0.00116	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—uterine cancer	0.000935	0.00116	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—uterine cancer	0.000934	0.00116	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—uterine cancer	0.000923	0.00114	CcSEcCtD
Hyoscyamine—Feeling abnormal—Etoposide—uterine cancer	0.000902	0.00112	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000901	0.00112	CcSEcCtD
Hyoscyamine—Nausea—Dactinomycin—uterine cancer	0.000899	0.00111	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Etoposide—uterine cancer	0.000895	0.00111	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—uterine cancer	0.00089	0.0011	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—uterine cancer	0.000879	0.00109	CcSEcCtD
Hyoscyamine—Urticaria—Etoposide—uterine cancer	0.00087	0.00108	CcSEcCtD
Hyoscyamine—Abdominal pain—Etoposide—uterine cancer	0.000866	0.00107	CcSEcCtD
Hyoscyamine—Body temperature increased—Etoposide—uterine cancer	0.000866	0.00107	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—uterine cancer	0.000866	0.00107	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—uterine cancer	0.000854	0.00106	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—uterine cancer	0.000814	0.00101	CcSEcCtD
Hyoscyamine—Hypersensitivity—Etoposide—uterine cancer	0.000807	0.001	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—uterine cancer	0.000802	0.000994	CcSEcCtD
Hyoscyamine—Asthenia—Etoposide—uterine cancer	0.000786	0.000974	CcSEcCtD
Hyoscyamine—Pruritus—Etoposide—uterine cancer	0.000775	0.00096	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—uterine cancer	0.000772	0.000957	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—uterine cancer	0.000757	0.000938	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—uterine cancer	0.000752	0.000932	CcSEcCtD
Hyoscyamine—Diarrhoea—Etoposide—uterine cancer	0.000749	0.000929	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—uterine cancer	0.000742	0.00092	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—uterine cancer	0.000738	0.000915	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—uterine cancer	0.000736	0.000913	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—uterine cancer	0.00073	0.000906	CcSEcCtD
Hyoscyamine—Dizziness—Etoposide—uterine cancer	0.000724	0.000898	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—uterine cancer	0.000714	0.000885	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—uterine cancer	0.000709	0.000879	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—uterine cancer	0.0007	0.000868	CcSEcCtD
Hyoscyamine—Vomiting—Etoposide—uterine cancer	0.000696	0.000863	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—uterine cancer	0.000696	0.000863	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—uterine cancer	0.000691	0.000857	CcSEcCtD
Hyoscyamine—Rash—Etoposide—uterine cancer	0.00069	0.000856	CcSEcCtD
Hyoscyamine—Dermatitis—Etoposide—uterine cancer	0.00069	0.000855	CcSEcCtD
Hyoscyamine—Headache—Etoposide—uterine cancer	0.000686	0.00085	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—uterine cancer	0.000683	0.000847	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—uterine cancer	0.000681	0.000845	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—uterine cancer	0.000676	0.000838	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—uterine cancer	0.000676	0.000838	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—uterine cancer	0.000674	0.000836	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—uterine cancer	0.000665	0.000824	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—uterine cancer	0.000661	0.000819	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—uterine cancer	0.000656	0.000813	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—uterine cancer	0.000652	0.000808	CcSEcCtD
Hyoscyamine—Nausea—Etoposide—uterine cancer	0.00065	0.000806	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—uterine cancer	0.00064	0.000794	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—uterine cancer	0.000639	0.000793	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—uterine cancer	0.000638	0.000791	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—uterine cancer	0.000626	0.000776	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—uterine cancer	0.000625	0.000775	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—uterine cancer	0.000624	0.000774	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—uterine cancer	0.000619	0.000767	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—uterine cancer	0.000615	0.000762	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—uterine cancer	0.000614	0.000761	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—uterine cancer	0.000614	0.000761	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—uterine cancer	0.000612	0.000758	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—uterine cancer	0.000604	0.000749	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—uterine cancer	0.000603	0.000747	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—uterine cancer	0.000599	0.000743	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—uterine cancer	0.000593	0.000736	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—uterine cancer	0.000592	0.000734	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—uterine cancer	0.00059	0.000732	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—uterine cancer	0.000579	0.000718	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—uterine cancer	0.000574	0.000711	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—uterine cancer	0.000573	0.00071	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—uterine cancer	0.000568	0.000704	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000568	0.000704	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—uterine cancer	0.000559	0.000693	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—uterine cancer	0.000555	0.000688	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—uterine cancer	0.000554	0.000687	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000549	0.000681	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—uterine cancer	0.000547	0.000678	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—uterine cancer	0.000546	0.000676	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—uterine cancer	0.00054	0.00067	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—uterine cancer	0.000531	0.000658	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—uterine cancer	0.000529	0.000656	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—uterine cancer	0.000525	0.000651	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—uterine cancer	0.000525	0.000651	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—uterine cancer	0.000514	0.000637	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—uterine cancer	0.000506	0.000628	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—uterine cancer	0.000506	0.000627	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—uterine cancer	0.000505	0.000626	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000502	0.000622	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—uterine cancer	0.0005	0.00062	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—uterine cancer	0.00049	0.000607	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—uterine cancer	0.000488	0.000604	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—uterine cancer	0.000486	0.000602	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—uterine cancer	0.000486	0.000602	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—uterine cancer	0.000485	0.000602	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—uterine cancer	0.000485	0.000602	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000468	0.00058	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000464	0.000576	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—uterine cancer	0.000452	0.000561	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—uterine cancer	0.000451	0.000559	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—uterine cancer	0.000449	0.000557	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—uterine cancer	0.000449	0.000557	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—uterine cancer	0.00044	0.000546	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—uterine cancer	0.000434	0.000538	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—uterine cancer	0.00042	0.000521	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—uterine cancer	0.000418	0.000519	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—uterine cancer	0.000407	0.000505	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—uterine cancer	0.000406	0.000503	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—uterine cancer	0.000402	0.000498	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—uterine cancer	0.00039	0.000484	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—uterine cancer	0.000389	0.000482	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—uterine cancer	0.000387	0.00048	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—uterine cancer	0.000387	0.000479	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—uterine cancer	0.000385	0.000477	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—uterine cancer	0.000376	0.000466	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—uterine cancer	0.000365	0.000452	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—uterine cancer	0.000361	0.000448	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—uterine cancer	0.000358	0.000444	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—uterine cancer	0.000358	0.000444	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—uterine cancer	0.000356	0.000441	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—uterine cancer	0.000337	0.000418	CcSEcCtD
